4.4 Article

Intracerebroventricular infusion of neuropeptide Y increases glucose dependent-insulinotropic peptide secretion in the fasting conscious dog

期刊

PEPTIDES
卷 29, 期 12, 页码 2281-2285

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.peptides.2008.08.024

关键词

-

向作者/读者索取更多资源

The rapid increase of incretins glucose - dependent insulinotropic peptide (GIP) and glucagon like peptide-1 (GLP-1), within 5-15 min, after food ingestion, suggests that a neural mechanism might be involved in the regulation of their secretion. The aim of this study is to determine whether intracerebroventricular (i.c.v) administration of neuropeptide Y (NPY), a widely distributed neurotransmmiter, can mediate this neural regulation of GIP secretion after food consumption. Six healthy mongrel dogs were utilized for this study. A prototype epicranial apparatus was placed surgically, allowing easy and exact localization of the third ventricle for infusions or sampling. Simultaneous blood sampling was obtained from cannulation. of a hind limb vein. Plasma insulin, and GIP concentrations were measured after i.c.v infusion of S, 10 and 25 mu g of NPY dissolved in 0.5 ml of artificial cerebrospinal fluid (a CSF). The secretion of GIP and insulin were increased after the injection of NPY in a different pattern. our data indicate that NPY might be involved in a possible neural control mechanism of GIP secretion after food consumption. 2008 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Analytical

Rapid and Sensitive SERS-Based Lateral Flow Test for SARS-CoV2-Specific IgM/IgG Antibodies

Supriya Srivastav, Asen Dankov, Mujo Adanalic, Roland Grzeschik, Vi Tran, Sibylle Pagel-Wieder, Frank Gessler, Ingo Spreitzer, Tatjana Scholz, Barbara Schnierle, Olympia E. Anastasiou, Ulf Dittmer, Sebastian Schluecker

Summary: The study compared the performance of a conventional lateral flow assay (LFA) with a surface-enhanced Raman scattering (SERS)-based LFA test in detecting SARS-CoV-2-specific IgM/IgG in sera of COVID-19 patients. The custom-built SERS reader showed at least an order of magnitude higher sensitivity than conventional LFAs with naked-eye detection. SERS detection in a purified system showed a sensitivity that is 7 orders of magnitude higher than naked-eye detection, indicating the high potential of SERS-based LFAs in point-of-care testing.

ANALYTICAL CHEMISTRY (2021)

Article Medicine, General & Internal

Wave riding-12 months of COVID-19 in a German tertiary care center

David Fistera, Dirk Pabst, Maximilian Falk, Olympia E. Anastasiou, Stefan Goer, Sebastian Dolff, Margarethe Konik, Frank Herbstreit, Christian Taube, Clemens Kill, Joachim Risse

Summary: During the first twelve months of the COVID-19 pandemic, the university hospital of Essen had over 1400 COVID-19 inpatients with a mortality rate of 19.8%. Patients receiving standard care had a mortality rate of 10.6%, while those requiring intermediate/intensive care had a mortality rate of 35.5%. Age over 60, obesity, need for mechanical ventilation, nitric oxide therapy, ECMO, acute renal failure, and stroke were found to be independent predictors of mortality.

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2022)

Article Immunology

Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination

Krystallenia Paniskaki, Moritz Anft, Toni L. Meister, Corinna Marheinecke, Stephanie Pfaender, Sarah Skrzypczyk, Felix S. Seibert, Constantin J. Thieme, Margarethe J. Konik, Sebastian Dolff, Olympia Anastasiou, Bodo Holzer, Ulf Dittmer, Christine Queren, Lutz Fricke, Hana Rohn, Timm H. Westhoff, Oliver Witzke, Ulrik Stervbo, Toralf Roch, Nina Babel

Summary: In this study, the immune response of 8 patients infected with the alpha variant after receiving double mRNA-based vaccines was analyzed. The results showed that these patients had no detectable CD4+ and CD8+ T cell response against the S protein of the alpha variant, but had a strong CD4+ T cell response against the N and M proteins. Furthermore, a delayed CD4+ T cell response against the alpha S protein was observed during disease progression. These patients also had lower neutralizing antibody titers against the alpha variant compared to the vaccinated control group. Therefore, it may be necessary to include VBI patients in alternative vaccination strategies and include additional antigenic targets in next-generation SARS-CoV-2 vaccines.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

The Course of Anti-HBc Antibodies over Time in Immunocompromised Hosts

Caroline Holtkamp, Melanie Fiedler, Ulf Dittmer, Olympia E. Anastasiou

Summary: This study analyzed the course of anti-HBc antibodies after hepatitis B virus infection and found that permanent or intermittent loss of anti-HBc antibodies is more common in immunocompromised hosts.

VACCINES (2022)

Article Immunology

Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis

Michael Jahn, Johannes Korth, Oliver Dorsch, Olympia Evdoxia Anastasiou, Adalbert Krawczyk, Leonie Brochhagen, Lukas van de Sand, Burkhard Sorge-Haedicke, Bartosz Tyczynski, Oliver Witzke, Ulf Dittmer, Sebastian Dolff, Benjamin Wilde, Andreas Kribben

Summary: This study analyzed the levels of binding and neutralizing antibodies up to 6 months after standard vaccination in SARS-CoV-2 naive patients on hemodialysis. The study found that there may be a decline in humoral immune responses in these patients after 6 months, increasing the risk of infection and transmission of SARS-CoV-2. Low serum albumin was identified as the strongest risk factor for the absence of immune responses.

VACCINES (2022)

Article Virology

COVID-19 in Elderly, Immunocompromised or Diabetic Patients-From Immune Monitoring to Clinical Management in the Hospital

Korbinian Wunsch, Olympia E. Anastasiou, Mira Alt, Leonie Brochhagen, Maxim Cherneha, Laura Thummler, Lukas van Baal, Rabea J. Madel, Monika Lindemann, Christian Taube, Oliver Witzke, Hana Rohn, Adalbert Krawczyk, Sarah Jansen

Summary: The highly transmissible SARS-CoV-2 virus has caused a global pandemic of acute respiratory illness, posing a major threat to the healthcare system's capacity to respond to COVID-19. Elderly and immunocompromised patients are at higher risk for severe disease and have reduced immune responses. This study aimed to characterize high-risk patient cohorts and investigate their immune responses and infectivity, providing valuable information for clinical management.

VIRUSES-BASEL (2022)

Article Immunology

Patients with Liver Cirrhosis Show High Immunogenicity upon COVID-19 Vaccination but Develop Premature Deterioration of Antibody Titers

Katharina Willuweit, Alexandra Frey, Moritz Passenberg, Johannes Korth, Nissrin Saka, Olympia E. Anastasiou, Birte Moehlendick, Andreas Schuette, Hartmut Schmidt, Jassin Rashidi-Alavijeh

Summary: Patients with liver cirrhosis showed a favorable initial outcome after vaccination with the COVID-19 vaccine, but the antibody response deteriorated rapidly over time, highlighting the importance of early booster immunization for this group of patients.

VACCINES (2022)

Article Immunology

Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections

Birte Moehlendick, Ieva Ciuciulkaite, Carina Elsner, Olympia E. Anastasiou, Mirko Trilling, Bernd Wagner, Denise Zwanziger, Karl-Heinz Joeckel, Ulf Dittmer, Winfried Siffert

Summary: The risk of developing an Omicron breakthrough infection was found to be 10 times higher in individuals with low pre-infection anti-spike antibodies and weaker neutralization capacity against Omicron one month after the booster vaccination. Routine testing of anti-SARS-CoV-2 IgG antibodies and surrogate virus neutralization can help identify individuals at risk for breakthrough infections.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Long-term cellular immune response in immunocompromised unvaccinated COVID-19 patients undergoing monoclonal antibody treatment

Laura Thuemmler, Margarethe Konik, Monika Lindemann, Neslinur Fisenkci, Michael Koldehoff, Anja Gaeckler, Peter A. Horn, Fotis Theodoropoulos, Christian Taube, Markus Zettler, Olympia Evdoxia Anastasiou, Peer Brass, Sarah Jansen, Oliver Witzke, Hana Rohn, Adalbert Krawczyk

Summary: This study investigated the long-term cellular immune response to SARS-CoV-2 in immunocompromised high-risk patients. The results suggest that immunocompromised patients develop a weak cellular immune response after COVID-19.

FRONTIERS IN IMMUNOLOGY (2022)

Article Public, Environmental & Occupational Health

Associations Between Built Environment Factors and SARS-CoV-2 Infections at the Neighbourhood Level in a Metropolitan Area in Germany

Dennis Schmiege, Timo Haselhoff, Salman Ahmed, Olympia Evdoxia Anastasiou, Susanne Moebus

Summary: This study in a metropolitan area in Germany examined the association between built environment factors and SARS-CoV-2 infections. The results showed that urban greenness, rooms per person, and living space per person were negatively associated with neighborhood infection rates, while multi-storey buildings and green space did not show a substantial association. The findings highlight environmental health inequalities during the COVID-19 pandemic.

JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE (2023)

Article Multidisciplinary Sciences

Antibody responses elicited by mRNA vaccination in firefighters persist six months and correlate inversely with age and directly with BMI

Caroline Holtkamp, Lara Schoeler, Olympia E. Anastasiou, Bastian Brune, Kai Fessmann, Carina Elsner, Birte Moehlendick, Ieva Ciuciulkaite, Marcel Dudda, Mirko Trilling, Ulf Dittmer, Joerg Spors, Vu Thuy Khanh Le-Trilling

Summary: Knowledge regarding the sustainability of immune responses after COVID-19 vaccination is crucial for making decisions on booster shots. This study analyzed antibody levels in firefighters six months after receiving the mRNA-based vaccine Comirnaty. The results showed that antibody levels were still detectable in all participants and 91% had neutralizing antibody titers above 1:16 after six months. However, the antibody titers were over 12-fold lower compared to healthcare workers four weeks after vaccination. Age had an inverse correlation with antibody response and participants with a body mass index over 25 had higher neutralizing antibody titers after six months. Booster vaccination improved the extent and sustainability of antibody responses.

HELIYON (2023)

Article Immunology

Durability of Immune Response after Application of a Third Dose of SARS-CoV-2 Vaccination in Liver Transplant Recipients

Moritz Passenberg, Roxane Authorsen-Grudmann, Alexandra Frey, Johannes Korth, Jaqueline Zmudzinski, Olympia E. Anastasiou, Birte Moehlendick, Hartmut Schmidt, Jassin Rashidi-Alavijeh, Katharina Willuweit

Summary: Immunogenicity is impaired in liver transplant recipients after SARS-CoV-2 vaccination, but a third dose improves antibody response. In the general population, antibody response decreases over time after two vaccine doses, but is more robust after the third dose. The durability of antibody response after a third dose in liver transplant recipients has not been analyzed. A study of 300 recipients showed that 74% developed antibodies after two doses, with response depending on medication and age. Antibody titers decreased after six months, but increased in 92% of patients after the third dose. After a further six-month period, the waning of antibody titers was not significant. This study confirms the efficacy of a third dose in liver transplant recipients and a sustained humoral response with superior durability compared to the second dose.

VACCINES (2023)

Article Infectious Diseases

A simple algorithm based on initial Ct values predicts the duration to SARS-CoV-2 negativity and allows more efficient test-to-release and return-to-work schedules

Olympia E. Anastasiou, Vu Thuy Khanh Le-Trilling, Mirko Trilling

Summary: During pandemics and epidemic waves, the capacity for qRT-PCRs becomes a limiting factor. This study investigates the association between initial Ct values of SARS-CoV-2 infection and the time to test negativity, proposing an adjusted retesting strategy based on the initial Ct value to optimize PCR resources.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2023)

Article Virology

Burden of HPV-Related Hospitalization in Germany from 2000 to 2021

Georgios Tampakoudis, Olympia E. Anastasiou

Summary: This study aimed to evaluate the burden of HPV-related hospitalization in Germany from 2000 to 2021 and the potential impact of the COVID-19 pandemic on it. The results showed a decreasing trend in HPV-attributable hospitalization rates, particularly in cervical cancer and dysplasia, suggesting the potential efficacy of HPV vaccination and screening programs.

VIRUSES-BASEL (2023)

Article Medicine, General & Internal

Evaluation of a new COVID-19 triage algorithm in the emergency department including combined antigen and PCR-testing: A case-control study

David Fistera, Tobias Hoelscher, Dirk Pabst, Randi Manegold, Olympia E. Anastasiou, Sebastian Dolff, Clemens Kill, Joachim Risse

Summary: The COVID-19 pandemic has posed a major challenge to global healthcare systems. This study found that rapid antigen testing can help improve early triage and patient safety in the emergency department. The suggested triage algorithm was shown to be safe and efficient in the study.

MEDICINE (2022)

Article Biochemistry & Molecular Biology

The dual incretin co-agonist tirzepatide increases both insulin secretion and glucose effectiveness in model experiments in mice

Giovanni Pacini, Bo Ahren

Summary: Tirzepatide stimulates both insulin secretion and glucose effectiveness, with stimulation of glucose effectiveness being the prominent process to reduce glucose.

PEPTIDES (2024)

Article Biochemistry & Molecular Biology

Endomorphin-2 analogs with C-terminal esterification display potent antinociceptive effects in the formalin pain test in mice

Si -yu Wang, Yu-zhe Zhang, Xiao-han Liu, Xue-ci Guo, Xiao-fang Wang, Feng-tong Han, Yao Zhang, Chang -lin Wang

Summary: In the formalin pain test, the EM-2 analogs EM-2-Me, EM-2-Et, and EM-2-Bu showed significant analgesic effects with reduced tolerance and gastrointestinal side effects. These effects were mediated through central opioid mechanisms, with EM-2-Me possibly involving dynorphin A release and EM-2-Bu directly activating multiple opioid receptors.

PEPTIDES (2024)